Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
GMAB:NASDAQ
Genmab A/S - ADR
$26.87
-0.41%
(-0.11) 1D
$26.90
+0.11% (+0.030)
After hours
Closed: Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GMAB...
Open
$26.97
High
$27.11
Low
$26.80
Mkt. cap
16.96B
Avg. vol.
1.65M
Volume
1.09M
P/E ratio
17.49
52-wk high
$35.43
52-wk low
$18.88
EPS
$1.54
Beta
0.97
Shares outstanding
642.51M
No. of employees
3K
News stories
From sources across the web
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees2.97K
Founded1999
Headquarters-
SectorBiotechnology
Websitegenmab.com
Last report
Feb 17, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
12.95/ (24.87 est.)DKK
-47.90%miss
Revenue / Estimate
6.68B/ (6.69B est.)DKK
-0.15%miss
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Revenue
4.68B
4.14B
5.40B
5.54B
Cost of goods sold
-
-
-
273.00M
Cost of revenue
-
-
-
273.00M
Research and development expenses
-
-
-
2.28B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
865.00M
Operating expense
-
-
-
3.15B
Total operating expenses
-
-
-
3.42B
Operating income
-
-
-
2.12B
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
1.72B
EBT excluding unusual items
-
-
-
1.59B
Income tax expense
-
-
-
453.00M
Effective tax rate
-
-
-
26.35%
Other operating expenses
-
-
-
-
Net income
-
-
-
1.27B
Net profit margin
-
-
-
22.85%
Earnings per share
9.67
-
-
19.81
Interest and investment income
-
-
-
162.00M
Interest expense
-
-
-
-18.00M
Net interest expenses
-
-
-
144.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
2.20B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer